The role of cAMP regulation in controlling inflammation
Open Access
- 1 September 1995
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 101 (3), 387-389
- https://doi.org/10.1111/j.1365-2249.1995.tb03123.x
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Overview: Cardiovascular & Renal; Cyclic nucleotide phosphodiesterase inhibitorsExpert Opinion on Therapeutic Patents, 1995
- Nitric Oxide Production by Murine Macrophages Is Inhibited by Prolonged Elevation of Cyclic AMPBiochemical and Biophysical Research Communications, 1993
- Isoenzyme selective phosphodiesterase inhibitors: potential clinical uses.British Journal of Clinical Pharmacology, 1993
- Minireview: Interactions between second messengers: Cyclic AMP and phospholipase A2- and phospholipase C-metabolitesLife Sciences, 1991
- Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.Thorax, 1991
- Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: arachidonic acid and its metabolites as second messengersTrends in Neurosciences, 1988
- Quantitative studies on cell-mediated immunity in the pleural cavity of guinea-pigsThe Journal of Pathology, 1975
- Further studies on carrageenan‐induced pleurisy in ratsThe Journal of Pathology, 1975
- Calcium pyrophosphate-induced pleurisy in rats: A new model of acute inflammationInflammation Research, 1975
- Modulation of Inflammation and Immunity by Cyclic AMPScience, 1974